Useful Links

Market Sectors

FREQUENTLY ASKED QUESTIONS
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy
USING 3HP REGIMEN FOR LTBI
Safety & PK of weekly rifapentine/isoniazid (3HP) in adults with HIV on dolutegravir. 4–7 March 2019
Cytokine-mediated systemic adverse drug reactions FOR drug-drug interaction study of dolutegravir with once-weekly isoniazid and rifapentine.